结节病患者心脏磁共振成像上的右心室异常
研究纳入290例活检证实的结节病患者,评估心脏磁共振右心室收缩功能障碍(男性RVEF<40%、女性<45%)和右心室延迟钆增强的患病率及预后价值。右心室收缩功能障碍与全因死亡独立相关,而右心室延迟钆增强与心律失常复合终点独立相关。
要点
- 结节病患者中右心室收缩功能障碍(RVEF<40%男性、<45%女性)患病率12.1%,右心室延迟钆增强患病率5.5%。
- 右心室射血分数每降低1%,全因死亡风险独立增加(HR 1.05,95%CI 1.01–1.09,p=0.022)。
- 右心室延迟钆增强与心律失常复合终点独立相关(HR 5.43,95%CI 1.25–23.47,p=0.024)。
关键影像表现/征象
- 右心室收缩功能障碍定义为男性RVEF<40%、女性RVEF<45%,在35例(12.1%)中存在。
- 右心室延迟钆增强在16例(5.5%)中存在。
诊断标准与关键数值
- 右心室收缩功能障碍定义为右心室射血分数<40%(男性)和<45%(女性)。
- 右心室射血分数与全因死亡独立相关(每降低1%,HR 1.05,95%CI 1.01–1.09,p=0.022),校正左心室射血分数、左心室延迟钆增强范围和右心室延迟钆增强存在后。
- 右心室射血分数与心律失常终点无关(HR 1.01,95%CI 0.96–1.06,p=0.67)。
- 右心室延迟钆增强与全因死亡无关(HR 2.78,95%CI 0.36–21.66,p=0.33)。
- 右心室延迟钆增强与心律失常终点独立相关(HR 5.43,95%CI 1.25–23.47,p=0.024)。
临床应用与阅片要点
- 在结节病患者心脏磁共振报告中,应描述右心室射血分数和右心室延迟钆增强,因二者预后关联不同。
- 右心室射血分数降低与全因死亡风险相关,右心室延迟钆增强与心律失常风险相关,可能对右心室异常的管理有不同意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to determine the prevalence on cardiac magnetic resonance (CMR) of right ventricular (RV) systolic dysfunction and RV late gadolinium enhancement (LGE), their determinants, and their influences on long-term adverse outcomes in patients with sarcoidosis.
BACKGROUND: In patients with sarcoidosis, RV abnormalities have been described on many imaging modalities. On CMR, RV abnormalities include RV systolic dysfunction quantified as an abnormal right ventricular ejection fraction (RVEF), and RV LGE.
METHODS: Consecutive patients with biopsy-proven sarcoidosis who underwent CMR for suspected cardiac involvement were studied. They were followed for 2 endpoints: all-cause death, and a composite arrhythmic endpoint of sudden cardiac death or significant ventricular arrhythmia.
RESULTS: Among 290 patients, RV systolic dysfunction (RVEF <40% in men and <45% in women) and RV LGE were present in 35 (12.1%) and 16 (5.5%), respectively. The median follow-up time was 3.2 years (interquartile range [IQR]: 1.6 to 5.7 years) for all-cause death and 3.0 years (IQR: 1.4 to 5.5 years) for the arrhythmic endpoint. On Cox proportional hazards regression multivariable analyses, only RVEF was independently associated with all-cause death (hazard ratio [HR]: 1.05 for every 1% decrease; 95% confidence interval [CI]: 1.01 to 1.09; p = 0.022) after adjustment for left ventricular EF, left ventricular LGE extent, and the presence of RV LGE. RVEF was not associated with the arrhythmic endpoint (HR: 1.01; 95% CI: 0.96 to 1.06; p = 0.67). Conversely, RV LGE was not associated with all-cause death (HR: 2.78; 95% CI: 0.36 to 21.66; p = 0.33), while it was independently associated with the arrhythmic endpoint (HR: 5.43; 95% CI: 1.25 to 23.47; p = 0.024).
CONCLUSIONS: In this study of patients with sarcoidosis, RV systolic dysfunction and RV LGE had distinct prognostic associations; RV systolic dysfunction but not RV LGE was independently associated with all-cause death, whereas RV LGE but not RV systolic dysfunction was independently associated with sudden cardiac death or significant ventricular arrhythmia. These findings may indicate distinct implications for the management of RV abnormalities in sarcoidosis.
引用
- Velangi PS, Chen KA, Kazmirczak F, et al. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis. JACC Cardiovasc Imaging. 2020. PMID: 31954639. doi:10.1016/j.jcmg.2019.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。